review · 2025
Mavorixafor: a CXCR4 antagonist for WHIM syndrome
Mavorixafor 400mg daily effectively increases WBC count, reduces disease symptoms and infection burden in WHIM syndrome patients ≥12 years. Future clinical p...
1 citationsDOI: https://doi.org/10.1080/08923973.2025.2491551